Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1
HM Chang, R Moudgil, T Scarabelli… - Journal of the American …, 2017 - jacc.org
Modern cancer therapy has successfully cured many cancers and converted a terminal
illness into a chronic disease. Because cancer patients often have coexisting heart …
illness into a chronic disease. Because cancer patients often have coexisting heart …
[HTML][HTML] Cardiotoxicity and oncological treatments
A Schlitt, K Jordan, D Vordermark… - Deutsches Ärzteblatt …, 2014 - ncbi.nlm.nih.gov
Methods This article is based on pertinent articles that were retrieved by a selective search
in PubMed and other databases, and on the guidelines of the European Society of …
in PubMed and other databases, and on the guidelines of the European Society of …
Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease
BC Drafts, KM Twomley, R D'Agostino… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives: The goal of this study was to determine if low to moderate doses of anthracycline-
based chemotherapy (Anth-bC) are associated with subclinical cardiovascular (CV) injury …
based chemotherapy (Anth-bC) are associated with subclinical cardiovascular (CV) injury …
ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology …
LK Newby, RL Jesse, JD Babb, RH Christenson… - Journal of the American …, 2012 - jacc.org
This document was approved by the American College of Cardiology Foundation (ACCF)
Board of Trustees in August 2012 and by the following societies in August 2012: American …
Board of Trustees in August 2012 and by the following societies in August 2012: American …
Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol
GC Pereira, AM Silva, CV Diogo… - Current …, 2011 - ingentaconnect.com
Mitochondria have long been involved in several cellular processes beyond its role in
energy production. The importance of this organelle for cardiac tissue homeostasis has …
energy production. The importance of this organelle for cardiac tissue homeostasis has …
Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients
S Tian, KM Hirshfield, SK Jabbour, D Toppmeyer… - Frontiers in …, 2014 - frontiersin.org
Multi-modality cancer treatments that include chemotherapy, radiation therapy, and targeted
agents are highly effective therapies. Their use, especially in combination, is limited by the …
agents are highly effective therapies. Their use, especially in combination, is limited by the …
I Diretriz Brasileira de cardio-oncologia da Sociedade Brasileira de Cardiologia
As doenças cardiovasculares nos pacientes com câncer são eventos cada vez mais
frequentes, em decorrência de avanços na terapêutica oncológica que resultaram tanto na …
frequentes, em decorrência de avanços na terapêutica oncológica que resultaram tanto na …
Circulating micro RNA s: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy
KJ Leger, D Leonard, D Nielson… - Journal of the …, 2017 - Am Heart Assoc
Background Biomarkers for early detection of anthracycline (AC)‐induced cardiotoxicity may
allow cardioprotective intervention before irreversible damage. Circulating micro RNA s (mi …
allow cardioprotective intervention before irreversible damage. Circulating micro RNA s (mi …
[HTML][HTML] Cardiac troponin and heart failure in the era of high-sensitivity assays
Y Sato, H Fujiwara, Y Takatsu - Journal of cardiology, 2012 - Elsevier
The Joint European Society of Cardiology-American College of Cardiology Foundation-
American Heart Association-World Heart Federation Task Force for the Redefinition of …
American Heart Association-World Heart Federation Task Force for the Redefinition of …
Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats
W Arozal, K Watanabe, PT Veeraveedu, M Ma… - Toxicology, 2010 - Elsevier
Daunorubicin (DNR) is one of the anthracycline anti-tumor agents widely used in the
treatment of acute myeloid leukemia. However, the clinical use of DNR has been limited by …
treatment of acute myeloid leukemia. However, the clinical use of DNR has been limited by …